Lincoln International Closed / Announced Six Transactions in Q4 2020 in the Pet and Animal Health Sectors

The pet and animal sectors continue to demonstrate resilience across the economic cycle; mergers and acquisitions (M&A) activity has proven investor appetite remains strong, even in the face of uncertainty as a result of the pandemic. Numerous attractive tailwinds, such as increased pet adoptions during lockdown and the humanization of pets, have kept investors watching the industry closely for opportunities.

Lincoln International closed six pet transactions in Q4 2020 across our Global Consumer and Healthcare Groups, including cross-border sales to both public and private equity clients. Acting as both buy-side and sell-side advisors for a variety of clients, from branded pet food to treats and consumables to veterinary services, notable deals include:

Lincoln’s Global Healthcare Group continued their strong momentum in animal health. The Group has completed 50+ animal health transactions across all verticals, including hospitals, diagnostics, pharmaceuticals and technology.

As 2021 unfolds, Lincoln International expects M&A activity in this space to continue to be high. Connect with a senior member of the Lincoln International team to learn more.

Meet our Senior Team in Consumer

Meet our Senior Team in Healthcare

Recent Perspectives

Dividend Recapitalizations: Hit the Market Before M&A Activity Rebounds

Private debt funds have increased their dry power to $506.2 billion and acquisition-related private debt volume has reached all-time lows. As a result, private debt investors have become more aggressive… Read More

Affärsvärlden | European Companies Performing Well

Originally posted by Affärsvärlden on March 14, 2024. European companies are outperforming their U.S. counterparts. Proprietary data provided by Lincoln’s Valuations & Opinions Group revealed that European medium-sized companies are… Read More

Molecule to Market Podcast: M&A Roundtable and 2024 Predictions

Originally posted by Molecule to Market on March 8, 2024. James West, Managing Director in Lincoln’s Healthcare Group, recently joined the Molecule to Market podcast’s roundtable episode where he shared… Read More

A Paws in the March of Premium Pet: Inflationary Pressure Hits European Pet Foods

In an era where many pet owners lavish their fur babies with everything from spa treatments to gourmet meals, the premium pet food industry highlights the strong bond between humans… Read More